BUPRENORPHINE 15 MCG/HR PATCH

buprenorphine
$44.1510per EA
DEA Schedule CIII

Strength

15 ug/h

Manufacturer

Alvogen Inc.

NDC

47781041904

Classification

Generic

Dosage Form

PATCH, EXTENDED RELEASE

Route

TRANSDERMAL

Last Updated

4/22/2026

Active Ingredients

BUPRENORPHINE

Approval Type

Generic (ANDA)

FDA Application

ANDA207490

On Market Since

5/17/2022

Pharmacological Classes

Partial Opioid Agonist
Partial Opioid Agonists

Price History

1W

0.0%

1M

-7.2%

3M

-10.9%

6M

-9.0%

1Y

-17.8%

3Y

-28.3%

5Y

N/A

All

-39.9%